	US 11,672,798 B2
	Ciprofloxacin ophthalmic topical composition for treating ocular disease
Sandra Marchán Sancho, Esplugues de Llobregat (ES); Francisca Toribio Santisteban, Esplugues de Llobregat (ES); and María Isabel Delgado Gañán, Barcelona (ES)
Assigned to LABORATORIOS SALVAT, S.A., Esplugues de Llobregat (ES)
Filed by LABORATORIOS SALVAT, S.A., Esplugues de Llobregat (ES)
Filed on Dec. 23, 2021, as Appl. No. 17/561,631.
Claims priority of application No. 21382493 (EP), filed on Jun. 3, 2021.
Prior Publication US 2022/0387422 A1, Dec. 8, 2022
Int. Cl. A61K 31/496 (2006.01); A61K 9/00 (2006.01); A61K 31/573 (2006.01)

CPC A61K 31/496 (2013.01) [A61K 9/0048 (2013.01); A61K 31/573 (2013.01)]

14 Claims

1. A method for treating an ocular bacterial infection, the method comprising topical ophthalmic administration of a combination comprising ciprofloxacin, or a pharmaceutically acceptable salt thereof, and fluocinolone acetonide to a subject in need thereof.